NEW YORK (GenomeWeb News) – DNA2.0 on Monday announced a deal with Cosmo Bio to distribute DNA2.0's complete line of bioengineering products.
Financial and other terms of the deal were not disclosed.
Customers can access DNA2.0's products directly, but the deal with Cosmo Bio provides customers in Japan added flexibility and time savings, as well as service and support, DNA2.0 said.
Based in Menlo Park, Calif., is a synthetic biology firm and the largest provider of synthetic genes in the US, it said. Cosmo Bio, based in Tokyo, provides life science products to researchers in Japan and elsewhere.